Innovaderm, a leading clinical research organization (CRO), is excited to reveal a major rebranding to Indero, with immediate effect.The new brand identity reinforces the company’s dual focus on ...

Virtual medical scribing software has revolutionized patient care and made documentation more efficient in the healthcare industry. When selecting virtual medical scribing software, looking for ...

Postpartum hemorrhage (PPH) continues to challenge obstetric care despite ongoing medical advancements. With blood loss exceeding 500 ml in 6.3% to 13% of births and over 1000 ml in 1.9% to 2.8% of ...

Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues ...

Importance of DNA A nalysis:. DNA analysis’s primary goal is to create a visual representation of DNA. A DNA “image” resembles a fingerprint taken from a flat surface with columns of dark-colored ...

"We are thrilled to obtain the CE mark for our MosaiQ AiPlex CD microarray," said Manuel O. Mendez, CEO of AliveDx. "The MosaiQ fast portfolio expansion marks our fourth microarray CE mark approval in ...

AI Can Detect Lung Nodules: A new study has been unveiled at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancerin San Diego, CA citing promising ...

How AI is Transforming Vision Care? Read why Matthias Hofmann of Eyebot has to say in his byline article for Medical Device News Magazine.

NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the development of its first commercial product.The company has ...

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the completion of the ...

The Octave MSDA Test is being used by leading MS Centers of Excellence, academic institutions, and independent neurology practices across the United States, providing clinicians with critical ...

Trial achieves positive results in the treatment of persistent atrial fibrillation. Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second ...